Emerging Biosimilars and research pipelines

Biosimilars Congress 2019 is included Keynote and Speakers sessions on the most recent examination intended to offer extensive worldwide exchanges that address current issues in Biosimilars Congress 2019

The success of innovator biologicals with downsides of high costs and patents expiring have contributed to development of Biosimilars coupled with advantage of regulations, adaptability by physicians and patients. Biosimilars being complex molecules need to have sound scientific strategic approach to development, manufacturing and research. Few legal issues have not dampened Biosimilar companies to have strong pipelines, quality and focused timelines to provide affordable and effective drugs to patients in need.

Biosimilars - The generic version of biologicals is not only an emerging trend but has paved its way to succeed and sustain in the world of pharmaceuticals. Biosimilars take credit for revolutionizing the development of targeted, effective and affordable biologic treatments required across various therapeutic areas like Oncology, Immunology, Endocrinology, Ophthalmology etc. This need has attracted major investors as the prospects are driven by streamlined regulatory guidelines with high adoption rate amongst physicians and patients.

·         Biotechnology medicinal products for different drugs

·         Future of next generation biosimilars

·         Biopharmaceuticals development

·         Biotechnology medicinal products for different drugs

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.